組織清理市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、類型、最終用途、地區和競爭對手分類，2021-2031年

全球組織透明度市場預計將從 2025 年的 1.3249 億美元成長到 2031 年的 1.8041 億美元，複合年成長率為 5.28%。

這項技術透過去除光散射脂質來清除生物檢體的雜質，從而實現對完整細胞結構的3D成像。推動此成長要素包括神經退化性疾病發生率的上升以及藥物研發中對高解析度3D成像的需求。生命科學領域的大量資金支持也為這項技術的進步提供了保障。例如，歐洲製藥工業協會聯合會（EFPIA）在2024年發布的報告顯示，製藥業已在歐洲研發領域投資約550億歐元，凸顯了這些先進技術獲得了強而有力的資金支持。

然而，更廣泛的市場擴張面臨的主要障礙在於如何管理和分析成像產生的大量資料集。處理從透明化檢體中獲得的Terabyte資料需要高效能運算資源，而小規模實驗室往往缺乏這種資源。這些與資料儲存和複雜影像重建相關的技術限制，阻礙了組織透明化通訊協定的廣泛應用及其與標準診斷流程的整合。

市場促進因素

神經系統疾病和神經退化性疾病的日益普遍是推動組織透明化技術應用的主要動力。科學家迫切需要解讀腦損傷的複雜立體結構。傳統的2D組織學方法往往不足以捕捉到理解阿茲海默症疾病所需的複雜神經連結和空間背景。組織透明化技術能夠實現全腦成像，從而可以全面觀察澱粉樣斑塊和Tau蛋白纖維的定位。根據阿茲海默症協會於2024年3月發布的《2024年阿茲海默症現況》報告，約有690萬65歲及以上的美國人患有老年失智症失智症，這顯示一場巨大的公共衛生危機推動了這項研究的迫切需求。

同時，高解析度顯微鏡和成像技術的進步顯著提升了組織透明化方法的實用性和價值。現代共聚焦顯微鏡和光片顯微鏡專為處理大型透明樣本而設計，能夠以細胞內水平的精度獲取體積數據。這一發展得益於產業的持續創新。具體而言，卡爾蔡司醫療技術股份公司（Carl Zeiss Meditec AG）於2024年12月發布的《2023/24年度報告》明確指出，公司已投入3.431億歐元用於研發，重點致力於改進視覺化工具。此外，布魯克公司（Bruker）在2024年公佈的財務業績也表明，其2023會計年度全年銷售額達29.6億美元，這充分體現了全球對生命科學解決方案和科學儀器的強勁需求。

市場挑戰

處理和分析大量資料集是全球組織透明化市場成長的主要障礙。雖然組織透明化技術能夠視覺化整個生物系統，但由此產生的高解析度3D影像會為每個樣本產生Terabyte級的複雜、非結構化資料。如此龐大的資料量會使標準實驗室系統不堪重負，儲存和重建的難度也造成了瓶頸，超過了樣本生成能力。因此，這些技術難以在小規模研究機構中應用，市場成長僅限於擁有先進運算能力的資源豐富的研究中心。

數位基礎設施的這種差距嚴重阻礙了市場的廣泛應用。影像處理對高效能運算的依賴造成了資料生成與其實際應用之間的脫節，阻礙了關鍵試劑和設備的獲取。根據2024年Pistoia Alliance的一項調查，54%的生命科學專業人士認為管理非結構化資料是高效實驗研究的主要障礙。由於組織透明化過程幾乎全部產生大規模非結構化影像數據，這項產業普遍面臨的挑戰直接降低了新用戶的潛在投資回報，減緩了組織透明化解決方案的商業性擴張。

市場趨勢

組織透明化和空間轉錄組學的融合是市場發展的一個重大趨勢，它將研究從構造成像轉向在完整的3D環境下進行詳細的分子分析。這項進展使科學家能夠在保留細胞間相互作用空間關係的同時繪製蛋白質分佈和基因表現圖譜，這對於發育生物學和免疫學的發展至關重要。開發相容的空間分析工具的公司數量激增，證明了這種多組體學策略的商業性成功。例如，10x Genomics 在 2024 年 2 月發布的 2023 年第四季和全年財務報告中顯示，其全年收入為 6.187 億美元，這主要得益於其基於先進組織製備技術的太空生物學平台的廣泛應用。

同時，將組織透明化技術應用於高通量3D球狀體和類器官模型，尤其是在藥物研發流程中，已成為顯著的趨勢。與用於解剖圖譜繪製的全器官透明化不同，這一趨勢側重於快速處理微組織，以便在生理上精確的腫瘤模型中評估藥物的毒性和療效。這種方法將體外篩檢與臨床結果聯繫起來，而癌症的嚴重負擔使得這種關聯的需求日益凸顯。根據美國癌症協會於2024年1月發布的《2024年癌症事實與數據》報告，預計2024年美國將新增超過200萬例癌症病例，凸顯了預測性非臨床模型對於加速開發有效癌症治療方法的重要性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球組織清算市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品類別（儀器、試劑盒/試劑、服務）
  • 按應用領域（神經學、腫瘤學、心臟科等）
  • 按類型（軟組織、硬組織）
  • 按應用領域（學術研究、產業界）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美組織透明化市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲組織清算市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區組織清算市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲組織清算市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲組織清算市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球組織清算市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Logos Biosystems
• Visikol, Inc.
• LifeCanvas Technologies
• Miltenyi Biotec
• Bio-Techne
• Abcam plc
• ClearLight Biotechnologies, Inc.
• FUJIFILM Corporation
• Thermo Fisher Scientific, Inc.
• Corning Incorporated

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Tissue Clearing Market is projected to expand from USD 132.49 Million in 2025 to USD 180.41 Million by 2031, reflecting a compound annual growth rate of 5.28%. This technique involves making biological specimens transparent by extracting light-scattering lipids, enabling the volumetric imaging of intact cellular frameworks. Key growth drivers include the rising incidence of neurodegenerative conditions and the necessity for high-resolution three-dimensional mapping in drug development. This progress is supported by significant life sciences funding; for instance, the European Federation of Pharmaceutical Industries and Associations reported in 2024 that the pharmaceutical sector invested approximately €55,000 million in European research and development, underscoring the strong financial support for these advanced tools.

Nevertheless, the broader expansion of the market faces a major obstacle in managing and analyzing the immense datasets resulting from imaging. Processing terabytes of data from cleared specimens demands high-performance computing resources that are often unavailable in smaller labs. This technical constraint related to data storage and complex image reconstruction restricts the widespread use of tissue clearing protocols and hinders their incorporation into standard diagnostic procedures.

Market Driver

The rising prevalence of neurological and neurodegenerative disorders serves as a major driver for tissue clearing adoption, as scientists urgently need to decode the complex three-dimensional structures of brain pathologies. Conventional 2D histology is often insufficient for capturing the intricate neural connections and spatial context needed to understand diseases such as Alzheimer's. Tissue clearing facilitates whole-brain imaging, offering a complete view of amyloid plaques and tau tangles in situ. According to the Alzheimer's Association's "2024 Alzheimer's Disease Facts and Figures" report from March 2024, approximately 6.9 million Americans aged 65 and older are living with Alzheimer's dementia, emphasizing the massive scale of the public health crisis fueling this research demand.

At the same time, improvements in high-resolution microscopy and imaging technologies have greatly increased the practicality and value of tissue clearing methods. Modern confocal and light-sheet microscopes are now designed to accommodate large, transparent samples, allowing for the capture of volumetric data with subcellular precision. This evolution is driven by ongoing industry innovation; specifically, Carl Zeiss Meditec AG noted in its December 2024 "Annual Report 2023/24" that €343.1 million was allocated to research and development, highlighting a commitment to improved visualization tools. Additionally, the financial strength of manufacturers is evident, as Bruker Corporation reported full-year 2023 revenues of $2.96 billion in 2024, indicating robust global demand for life science solutions and scientific instruments.

Market Challenge

The handling and analysis of massive datasets present a significant obstacle to the growth of the Global Tissue Clearing Market. Although tissue clearing techniques facilitate the visualization of whole biological systems, the resulting high-resolution three-dimensional images create terabytes of complex, unstructured data for each sample. This immense volume overloads standard laboratory systems, resulting in a bottleneck where storage and reconstruction difficulties exceed sample generation capabilities. As a result, smaller research facilities are discouraged from utilizing these methods, effectively confining market growth to well-resourced centers equipped with advanced computational power.

This gap in digital infrastructure severely hinders wider market adoption. The dependence on high-performance computing for image processing causes a disconnect between data creation and its practical application, stalling the acquisition of essential reagents and equipment. According to the Pistoia Alliance in 2024, 54% of life science professionals cited the management of unstructured data as a major impediment to efficient experimental research. Since tissue clearing produces almost entirely large-scale unstructured image data, this sector-wide challenge directly lowers the potential return on investment for new users, thereby retarding the commercial expansion of tissue clearing solutions.

Market Trends

A major evolution in the market is the combination of tissue clearing with spatial transcriptomics, shifting research from structural imaging to detailed molecular profiling within intact three-dimensional settings. This development enables scientists to map protein distribution and gene expression while preserving the spatial relationships of cellular interactions, which is essential for progress in developmental biology and immunology. The commercial success of this multi-omics strategy is demonstrated by the growth of firms creating compatible spatial profiling tools; for example, 10x Genomics reported in its February 2024 "Fourth Quarter and Full Year 2023 Financial Results" that full-year revenue reached $618.7 million, driven by the increasing use of spatial biology platforms that rely on advanced tissue preparation.

Concurrently, there is a noticeable shift toward applying tissue clearing to high-throughput 3D spheroid and organoid models, especially within pharmaceutical drug discovery workflows. Unlike whole-organ clearing, which targets anatomical mapping, this trend focuses on rapidly processing micro-tissues to assess drug toxicity and efficacy in physiologically accurate tumor models. This approach connects in vitro screening with clinical results, a need intensified by the heavy burden of oncological diseases. According to the American Cancer Society's "Cancer Facts & Figures 2024" report from January 2024, over 2 million new cancer cases are projected to be diagnosed in the United States in 2024, highlighting the critical need for these predictive preclinical models to expedite the creation of effective cancer treatments.

Key Market Players

• Logos Biosystems
• Visikol, Inc.
• LifeCanvas Technologies
• Miltenyi Biotec
• Bio-Techne
• Abcam plc
• ClearLight Biotechnologies, Inc.
• FUJIFILM Corporation
• Thermo Fisher Scientific, Inc.
• Corning Incorporated

Report Scope

In this report, the Global Tissue Clearing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tissue Clearing Market, By Product

• Instruments
• Kits & Reagents
• Services

Tissue Clearing Market, By Application

• Neurology
• Oncology
• Cardiology
• Others

Tissue Clearing Market, By Type

• Soft Tissue
• Hard Tissue

Tissue Clearing Market, By End use

• Academic Research
• Industrial

Tissue Clearing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tissue Clearing Market.

Available Customizations:

Global Tissue Clearing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tissue Clearing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Kits & Reagents, Services)
  • 5.2.2. By Application (Neurology, Oncology, Cardiology, Others)
  • 5.2.3. By Type (Soft Tissue, Hard Tissue)
  • 5.2.4. By End use (Academic Research, Industrial)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Tissue Clearing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Type
  • 6.2.4. By End use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tissue Clearing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Type
      • 6.3.1.2.4. By End use
  • 6.3.2. Canada Tissue Clearing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Type
      • 6.3.2.2.4. By End use
  • 6.3.3. Mexico Tissue Clearing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Type
      • 6.3.3.2.4. By End use

7. Europe Tissue Clearing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Type
  • 7.2.4. By End use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Tissue Clearing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Type
      • 7.3.1.2.4. By End use
  • 7.3.2. France Tissue Clearing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Type
      • 7.3.2.2.4. By End use
  • 7.3.3. United Kingdom Tissue Clearing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Type
      • 7.3.3.2.4. By End use
  • 7.3.4. Italy Tissue Clearing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Type
      • 7.3.4.2.4. By End use
  • 7.3.5. Spain Tissue Clearing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Type
      • 7.3.5.2.4. By End use

8. Asia Pacific Tissue Clearing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Type
  • 8.2.4. By End use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Tissue Clearing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Type
      • 8.3.1.2.4. By End use
  • 8.3.2. India Tissue Clearing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Type
      • 8.3.2.2.4. By End use
  • 8.3.3. Japan Tissue Clearing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Type
      • 8.3.3.2.4. By End use
  • 8.3.4. South Korea Tissue Clearing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Type
      • 8.3.4.2.4. By End use
  • 8.3.5. Australia Tissue Clearing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Type
      • 8.3.5.2.4. By End use

9. Middle East & Africa Tissue Clearing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Type
  • 9.2.4. By End use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Tissue Clearing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Type
      • 9.3.1.2.4. By End use
  • 9.3.2. UAE Tissue Clearing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Type
      • 9.3.2.2.4. By End use
  • 9.3.3. South Africa Tissue Clearing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Type
      • 9.3.3.2.4. By End use

10. South America Tissue Clearing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Type
  • 10.2.4. By End use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Tissue Clearing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Type
      • 10.3.1.2.4. By End use
  • 10.3.2. Colombia Tissue Clearing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Type
      • 10.3.2.2.4. By End use
  • 10.3.3. Argentina Tissue Clearing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Type
      • 10.3.3.2.4. By End use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Tissue Clearing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Logos Biosystems
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Visikol, Inc.
• 15.3. LifeCanvas Technologies
• 15.4. Miltenyi Biotec
• 15.5. Bio-Techne
• 15.6. Abcam plc
• 15.7. ClearLight Biotechnologies, Inc.
• 15.8. FUJIFILM Corporation
• 15.9. Thermo Fisher Scientific, Inc.
• 15.10. Corning Incorporated

16. Strategic Recommendations

17. About Us & Disclaimer